These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772 [TBL] [Abstract][Full Text] [Related]
3. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms. Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912 [TBL] [Abstract][Full Text] [Related]
6. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952 [TBL] [Abstract][Full Text] [Related]
9. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest. Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531 [TBL] [Abstract][Full Text] [Related]
10. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
12. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848 [TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1). Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696 [TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617 [TBL] [Abstract][Full Text] [Related]
16. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus. Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323 [TBL] [Abstract][Full Text] [Related]
17. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells. Ogunwobi OO; Beales IL Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146 [TBL] [Abstract][Full Text] [Related]
18. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
19. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors. Ding J; Tsuboi K; Hoshikawa H; Goto R; Mori N; Katsukawa M; Hiraki E; Yamamoto S; Abe M; Ueda N Mol Carcinog; 2006 Apr; 45(4):250-9. PubMed ID: 16385588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]